rs10514835
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The ENST00000710812.1(AOPEP):n.410+12581A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0177 in 152,300 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.018 ( 30 hom., cov: 33)
Consequence
AOPEP
ENST00000710812.1 intron
ENST00000710812.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.17
Publications
3 publications found
Genes affected
AOPEP (HGNC:1361): (aminopeptidase O (putative)) This gene encodes a member of the M1 zinc aminopeptidase family. The encoded protein is a zinc-dependent metallopeptidase that catalyzes the removal of an amino acid from the amino terminus of a protein or peptide. This protein may play a role in the generation of angiotensin IV. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0177 (2694/152300) while in subpopulation NFE AF = 0.0248 (1688/68024). AF 95% confidence interval is 0.0238. There are 30 homozygotes in GnomAd4. There are 1260 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 30 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AOPEP | XM_011519121.4 | c.2319+12581A>G | intron_variant | Intron 15 of 15 | XP_011517423.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AOPEP | ENST00000710812.1 | n.410+12581A>G | intron_variant | Intron 4 of 4 |
Frequencies
GnomAD3 genomes AF: 0.0177 AC: 2697AN: 152182Hom.: 31 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2697
AN:
152182
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0177 AC: 2694AN: 152300Hom.: 30 Cov.: 33 AF XY: 0.0169 AC XY: 1260AN XY: 74478 show subpopulations
GnomAD4 genome
AF:
AC:
2694
AN:
152300
Hom.:
Cov.:
33
AF XY:
AC XY:
1260
AN XY:
74478
show subpopulations
African (AFR)
AF:
AC:
284
AN:
41562
American (AMR)
AF:
AC:
345
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
146
AN:
3468
East Asian (EAS)
AF:
AC:
1
AN:
5184
South Asian (SAS)
AF:
AC:
53
AN:
4822
European-Finnish (FIN)
AF:
AC:
71
AN:
10620
Middle Eastern (MID)
AF:
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1688
AN:
68024
Other (OTH)
AF:
AC:
52
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
135
270
406
541
676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.